481 related articles for article (PubMed ID: 6510335)
1. [Properties of alkylating derivatives of estrogens].
Morozova TM; Merkulova TI; Martynov V; Iaguzhinskaia VP; Shkodinskaia EN
Eksp Onkol; 1984; 6(2):50-4. PubMed ID: 6510335
[TBL] [Abstract][Full Text] [Related]
2. Studies on the estrogenic activity of chlordecone (Kepone) in the rat: effects on uterine estrogen receptor.
Bulger WH; Muccitelli RM; Kupfer D
Mol Pharmacol; 1979 May; 15(3):515-24. PubMed ID: 91089
[No Abstract] [Full Text] [Related]
3. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
[TBL] [Abstract][Full Text] [Related]
4. [Comparative analysis of the interaction of various estrogens with the estrogen-receptor system of the uterus].
Fanchenko ND; Alekseeva ML; Minina LS; Novikov EA; Khel'mun DK
Biokhimiia; 1985 Nov; 50(11):1853-8. PubMed ID: 4063405
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
6. Relationship between type I and type II estrogen binding sites in the rat uterus.
Moses DF; Fridman O; De Nicola AF
Acta Physiol Pharmacol Latinoam; 1985; 35(4):451-7. PubMed ID: 2940805
[TBL] [Abstract][Full Text] [Related]
7. Binding characteristics of zearalenone analogs to estrogen receptors.
Kiang DT; Kennedy BJ; Pathre SV; Mirocha CJ
Cancer Res; 1978 Nov; 38(11 Pt 1):3611-5. PubMed ID: 698923
[TBL] [Abstract][Full Text] [Related]
8. [Thymidine kinase activity in mammary tumors of animals exposed to estradiol as an index of tumor hormone dependence].
Morozova TM; Plotnikova LIa
Vopr Onkol; 1982; 28(11):58-62. PubMed ID: 7147834
[TBL] [Abstract][Full Text] [Related]
9. In vivo estrogenic and antiestrogenic activity of phenolphthalein and derivative compounds.
Nieto A; García C; López de Haro MS
Biochem Int; 1990; 21(2):305-11. PubMed ID: 2403370
[TBL] [Abstract][Full Text] [Related]
10. [Estradiol derivatives: relationship between uterotrophic activity and affinity to the cytosol receptor].
Tang ZM; Chen MY; Zhang Q
Zhongguo Yao Li Xue Bao; 1983 Sep; 4(3):186-91. PubMed ID: 6228119
[No Abstract] [Full Text] [Related]
11. [Effect of 1,2-dimethylhydrazine on the level of specific binding and ligand affinity to the estradiol receptor in the cytosol of uterine tissue in CBA mice].
Morozova OV; Kushlinskiĭ NE
Eksp Onkol; 1987; 9(4):54-6. PubMed ID: 3678126
[TBL] [Abstract][Full Text] [Related]
12. Diethylstilbestrol binding to estrogen receptor in mammary tissue and uteri of C3H/HeJ mice.
Okey AB; Bondy GP
J Natl Cancer Inst; 1978 Sep; 61(3):719-24. PubMed ID: 278849
[No Abstract] [Full Text] [Related]
13. Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors.
Di Carlo F; Conti G; Reboani C; Racca S
Farmaco Sci; 1980 May; 35(5):425-9. PubMed ID: 7450040
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic properties of 3,9-dihydroxy-7,12-dimethylbenz[a]anthracene in rats.
Morreal CE; Schneider SL; Sinha DK; Bronstein RE
J Natl Cancer Inst; 1979 Jun; 62(6):1585-8. PubMed ID: 108445
[TBL] [Abstract][Full Text] [Related]
15. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland.
Johnson MD; Kenney N; Stoica A; Hilakivi-Clarke L; Singh B; Chepko G; Clarke R; Sholler PF; Lirio AA; Foss C; Reiter R; Trock B; Paik S; Martin MB
Nat Med; 2003 Aug; 9(8):1081-4. PubMed ID: 12858169
[TBL] [Abstract][Full Text] [Related]
16. [Estrogen and progesterone interactions on the estrogen receptor and thymidine kinase in the immature rat uterus].
Sakamoto S; Soh H; Kawasaki T; Okamoto R
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2172-6. PubMed ID: 7153594
[TBL] [Abstract][Full Text] [Related]
17. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants.
Bulger WH; Feil VJ; Kupfer D
Mol Pharmacol; 1985 Jan; 27(1):115-24. PubMed ID: 3965923
[TBL] [Abstract][Full Text] [Related]
19. Estrogenic properties of 3,9-dihydroxybenz[a]anthracene, a potential metabolite of benz[a]anthracene.
Schneider SL; Alks V; Morreal CE; Sinha DK; Dao TL
J Natl Cancer Inst; 1976 Dec; 57(6):1351-4. PubMed ID: 826653
[TBL] [Abstract][Full Text] [Related]
20. Dose dependent modulation of receptor dynamics and uterine growth in immature rat by estradiol: importance of an additional nuclear binding at 24 hr for long-term (72 hr) uterine growth.
Agarwal AK; Durani S; Setty BS
Endokrinologie; 1982 Jun; 79(2):235-41. PubMed ID: 7128542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
